Hypertrophic cardiomyopathy (HCM) — which affects an estimated 600,000 to 1.5 million Americans or 1 in 500 people — involves mutations that can cause heart muscle to thicken and other changes to the heart’s mitral valves and cells.

The six cell line collections developed by the Allen Institute allow researchers to look at the impact of different mutations associated with the disease at the molecular and cellular level — before symptoms appear. That could ultimately lead to the development of more effective treatments for HCM.”

From Axios.